NCT00493324View on ClinicalTrials.gov

Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Chronic Plaque Psoriasis
Interventions
DRUG

alefacept

Intramuscular

DRUG

polyvalent pneumococcal vaccine

Injection

Trial Locations (7)

10016

New York

10029

New York

35205

Birmingham

44106

Cleveland

92123

San Diego

A1B 3E1

St. John's

L3P 1A8

Markham

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY